Aug 12, 2020
Chemotherapy-induced Nausea & Vomiting Drugs Market, 2024 - Focus on Serotonin & NK1 Receptor Antagonists and Other Therapies
Mar 02, 2020
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
Jan 13, 2020
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Nov 12, 2019
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Updates
Oct 22, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)
Aug 05, 2019
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates
Jul 10, 2019
AKYNZEO® Oral now covered by the Ontario, Quebec and Non-Insured Health Benefits public drugs plans
Feb 26, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for IV Push
Feb 22, 2019
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018 and Recent Corporate Progress
Feb 05, 2019
Heron Therapeutics Announces Retirement of Robert Rosen as President
Jan 07, 2019
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
Nov 07, 2018
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress
Sep 18, 2018
Chemotherapy-Induced Nausea & Vomiting (CINV) Treatment - Worldwide Markets to 2026: A $3.62 Billion Opportunity
Aug 08, 2018
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress
Jul 23, 2018
Global Antiemetics Technologies and Markets, 2023 - Vestibular Disorders, The Emergence of Advanced Therapies & Patent Expiry
May 10, 2018
ESPGHAN Annual Meeting: New Study Finds Ginger Proven to Treat Vomiting in Children With Acute Gastroenteritis
Jan 04, 2018
Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS® for the Management of Post-operative Nausea & Vomiting
Jun 20, 2017
Global Antiemetic Drug Market to Grow at a CAGR of 6% by 2021 - Analysis By Application & Drug Class - Research and Markets